Answers are grounded in this paper and cite their sources.
Treatment of nonmuscle-invasive bladder cancer (NMIBC) is highly burdensome for patients, urologists, and the medical system, requiring frequent surveillance cystoscopies, biopsies, fulgurations, and resections. Long-term surveillance is associated with a high financial and psychological cost for patients.1 The investigators recruited 13 patients with up to 3 papillary lesions, less than 1 cm in size, and demonstrated the feasibility of intravesical cryotherapy as a novel technique for ablation of small low-grade lesions. The technique requires insufflation of the bladder by rigid cystoscopy with the use of intravesical liquid CO2. In their protocol, treatment is performed in just a few minutes under sedation. There were no reported adverse events. Most lesions were completely eradicated by cryotherapy, confirmed by postoperative biopsy of the site at 6 weeks. However, large lesions of nearly 1 cm were not completely eradicated in this protocol.2 This technique seems feasible for clinics and has the potential to be used as an alternative to clinic fulguration for small lesions. While novel and interesting, this technique does not necessarily address the burden of care in NMIBC but may offer an alternative to cautery-based fulguration. Further research is necessary to explore if cryotherapy is equivalent or superior to fulguration at eradicating small lesions, or perhaps better tolerated by patients, before the use of cryotherapy becomes more widespread.
No takes yet. Share an insight, caveat, or question.
Bogdana Schmidt (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: